MedTrace Logo

Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension

NCT00863135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2017-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of CPAP treatment on blood pressure in patients with sleep apnea syndrome (SAS) and refractory arterial hypertension (RAH).

Also, some of the mechanisms mediating SAS and RAH (systemic inflammation, oxidative stress, sympathetic hyperactivity) will be analyzed.

Conditions

Interventions

DEVICE

CPAP

continuous positive airways pressure

DEVICE

Control

Patients are 3 months without any change in their treatment, and are in the waiting list to come into the CPAP procedure after that time

Sponsors & Collaborators

  • Carlos III Health Institute

    collaborator OTHER_GOV

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Jaume Almirall, Dr · Corporació Parc Taulí

  • Juan-Carlos Martinez-Ocaña, Dr · Corporació Parc Tauli

  • Antonio Ferrer, Dr · Corporacio Parc Tauli

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863135 on ClinicalTrials.gov